Group items tagged

Over the last few years pharmacy and the role of pharmacy teams has changed dramatically. The introduction of technology and the integration of artificial intelligence (AI) within systems that provide healthcare and support to pharmacies holds great promise; for improving access to health, supporting patient outcomes, and optimising operational efficiency. Currently, the potential use of AI could span the whole of the medicines value chain, from AI-driven drug discovery to personalised medicines and automated dispensing systems. However, the rapid advancement of AI technology does raise several ethical concerns. This article will explore these concerns and how they can be addressed. In previous articles, I have discussed what underpins artificially intelligent machines and the importance of data. Datasets are the foundation on which AI algorithms learn and generate conclusions. The first step to understanding the potential ethical implications of AI across the pharmacy sector is to understand the data that is held within these foundational datasets. Patient privacy and data security AI systems in and outside of the pharmacy sector, which support patient care, rely heavily on vast amounts of medical data (patient medical records, PMR data, etc). However, the collection, storage, and use of such sensitive data can possibly bring significant privacy concerns. GDPR compliance is essential within the UK and ethical questions arise around data ownership, patient consent, and the possibility of data and cybersecurity breaches. As frontline healthcare professionals, we need to be able to support our patients when questions are asked about their data. For example, how can patients be sure their data is used only for its intended purposes? Is anonymised data truly safe from de-identification techniques that could expose private information?

On World Pharmacists' Day, the Council of the Pharmaceutical Society NI (PSNI) thanked pharmacists working in every sector of pharmacy in Northern Ireland (NI) for their continued service to the public. The theme of this year's International Pharmaceutical Federation's World Pharmacists' Day, (25 September 2022) was 'Pharmacy united in action for a healthier world'. In acknowledgement of the day, Dr. Jim Livingstone, president of the Council of the Pharmaceutical Society NI said: "The theme of this year's World Pharmacists' Day, 'Pharmacy united in action for a healthier world' highlights pharmacy's positive impact on health around the world and seeks to further strengthen solidarity amongst the profession. "In Northern Ireland, pharmacy played a prominent role in primary health care throughout the pandemic and remains the public's most trusted and accessible frontline health care profession. "As pharmacy continues to develop additional services for the public and encompasses broader roles for pharmacists than ever before, it is essential, no matter what pharmacy sector pharmacists practise in, that the Pharmaceutical Society NI's Code (Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland) remains at the core of pharmacists' practice. It is through this adherence to the Code, that pharmacy remains a united profession, providing positive health outcomes for patients and maintaining public trust.

The Council of Pharmaceutical Society NI (PSNI) has introduced an 8-week public consultation on proposed Guidance on Pharmacy Staffing Levels within registered premises. The principle-based Guidance seeks to assist Pharmacy Owners and Superintendents to ensure that each pharmacy has enough appropriately skilled and qualified staff to provide safe and effective pharmacy services to the public. All registered pharmacies will have to meet the standards set out in the Premises Standards, when commenced. PSNI said: "The proposed Guidance should also help ensure a working environment that will facilitate pharmacists to meet their professional obligations under the Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016)." "Whilst other health regulators have primary responsibility for systems regulation outside of regulated premises, we consider that the principles outlined in this Guidance, will be helpful for managers working with pharmacy teams in different settings."

The General Pharmaceutical Council (GPhC) has developed two new resources- Keeping patients safe being open and honest and Pharmacy team toolkit - learning from incidents, to help pharmacists and pharmacy technicians fulfil the duty of candour - the professional responsibility to be open and honest with patients if/when something goes wrong. The new resources bring together relevant existing policy, standards, and previous statements on the professional obligations of pharmacists and pharmacy technicians, with respect to candour. It also emphasises that the duty of candour is not an add on - it's a fundamental part of pharmacy professional practice. The responsibility to be open and honest applies even in difficult or challenging times and it's essential that professionals do the right thing for patients, their families and carers. Saying sorry meaningfully when things go wrong is vital for everyone involved. Given the link with issues around liability and indemnity, the National Pharmacy Association and the Pharmacists' Defence Association - as leading providers of professional indemnity - have also contributed to the new resources and highlighted the importance of openness and transparency in this context.

The business landscape worldwide is undergoing a significant transformation, shifting from a sole focus on profitability to incorporating a broader spectrum of considerations. Today, Environmental, Social, and Governance (ESG) criteria are integral to business operations, reflecting a commitment to sustainable and ethical practices alongside financial growth. ESG stands for three interconnected pillars: Environmental, focusing on reducing a company's ecological footprint; Social, addressing the impact on employees, diversity, equity, inclusion, and the broader community; and Governance, which ensures responsible management practices, ethical behavior, and compliance with regulations. This holistic approach is becoming a critical foundation for long-term success in various industries, including healthcare. For the UK healthcare and pharmacy sectors, integrating ESG not only aligns with global sustainability goals but also offers substantial benefits. This article delves into the specific implications of ESG for UK pharmacies, highlighting how they can leverage these practices to foster both community well-being and business success.

In a recent minute of meeting, the General Pharmaceutical Council (GPhC) explored the implications of its unique authority under the Regulation of Investigatory Powers Act (RIPA), granting powers for covert surveillance. Although never utilized, the GPhC is obligated to maintain appropriate policies for such actions. During a recent meeting, the pharmacy regulator discussed that the use of RIPA be brought to a future Council workshop to discuss issues including the "ethical implications of having and using the powers, the possible use of RIPA in online pharmacy investigations and retaining the powers to deal with future scenarios as yet unknown". Led by Chief Executive and Registrar, Duncan Rudkin, the discussion underscored the importance of having robust oversight mechanisms in place. The inspection report provided assurance that the GPhC's policies align with regulatory requirements.

The Royal Pharmaceutical Society (RPS) has expressed a neutral stance on assisted dying, while emphasising the importance of certain safeguards in any proposed legislation. In particular, they have urged the Bill Committee to include clauses addressing conscientious objection and criminal liability for health professionals involved. The Terminally Ill Adults (End of Life) Bill, which passed its second reading on 29 November 2024, would allow terminally ill adults to request assistance in ending their life, subject to safeguards and protections. The RPS has submitted a written response to a House of Commons committee examining the Bill, urging consideration of several key points. The RPS insisted that there should be "no obligation for any pharmacist to participate in any aspect of assisted dying if they feel this is against their personal beliefs." Instead, they proposed an "opt-in" model, allowing pharmacists and other healthcare professionals to choose to participate in aspects of assisted dying by completing the necessary training, rather than being required to "opt out." "This would help avoid the need for anyone ethically opposed to assisted dying to signpost to another health professional, as this can also pose an ethical dilemma." "This opt-in model would also help identify where it may be more difficult to access health professionals who are willing to support assisted dying, such as in a specific care setting or in remote regions," it explained.

The Royal Pharmaceutical Society (RPS) has taken a neutral stance on the Assisted Dying for Terminally Ill Adults (Scotland) Bill but underscores that pharmacists should have the right to refuse involvement in the process. The Bill, introduced to the Scottish Parliament by Liam McArthur MSP as a Private Members Bill, could make Scotland the first UK nation with assisted dying legislation if it passes into law. This week, the RPS in Scotland released its consultation response to the Scottish Parliament's Health, Social Care, and Sport Committee regarding the Bill, and made it clear that "the ability of pharmacists to conscientiously object to assisted dying is essential." The Society emphasised that "all pharmacists should have the right to take part, or not take part in the process, depending on their individual religious, moral or ethical beliefs." In its response, the RPS has also advocated for the inclusion of an opt-in section within the Bill.

In a rapidly evolving and competitive landscape, the pharmaceutical industry faces unique challenges when it comes to marketing its products and services. With stringent regulations, complex target audiences, and a need for trust and credibility, pharma companies need to employ effective marketing strategies to stand out in the crowd. In this blog article, we will explore some key marketing strategies for the pharma industry that can help boost their visibility, engage their target audience, and drive business growth. UNDERSTANDING THE UNIQUE LANDSCAPE The pharma industry operates in a highly regulated environment, where compliance and ethical considerations play a crucial role. Before diving into marketing strategies, it is essential to have a deep understanding of the industry's dynamics and the target audience. Researching the market, identifying patient needs, and studying the competitive landscape are vital steps in developing an effective marketing plan. EMBRACING DIGITAL TRANSFORMATION Digital transformation has revolutionized marketing across industries, and the pharma sector is no exception. Embracing digital channels and technologies can significantly enhance the reach and impact of marketing efforts. Pharma companies can leverage social media platforms, create engaging content, and build online communities to connect with patients, healthcare professionals, and other stakeholders. Implementing robust digital marketing strategies allows for personalized messaging, real-time communication, and targeted campaigns that resonate with the target audience.

There are many reasons why people choose to go vegan. For some, it's a matter of ethics, while others believe that veganism is the healthiest way to live. Whatever the reason, there are many benefits to be had by making the switch to a vegan lifestyle. Here are six of the most important ones: 1. YOU'LL LOSE WEIGHT If you're carrying around a few extra pounds, going vegan is a great way to shed them. A vegan diet is naturally lower in calories than one that includes meat and dairy, so you'll likely find yourself eating less without even trying. And since plant-based foods are typically packed with fiber, you'll feel full and satisfied after meals, without the need to overeat. You can do some research if you visit www.veganfitguide.com or by reading various online resources. Keep in mind that you may not lose weight immediately, as your body will need time to adjust to the new way of eating. But once it does, the pounds should start coming off. Additionally, since a vegan diet is typically rich in nutrient-dense foods like fruits, vegetables, and whole grains, you're likely to get all the vitamins and minerals you need, without having to take supplements.

When you visit a hospital, one of the last things that come to mind is worrying about legal aspects and what rights you might have - or lack. But these issues and your understanding of them are more important than ever. Knowing exactly what hospitals can legally and cannot do to you is an essential part of ensuring your protection as a patient when going in for care. In this blog post, we'll break down the legal details behind being treated at a hospital so that you can feel more confident when making healthcare decisions. Let's dive into the legal aspect of visiting a hospital, outline what hospitals can and cannot do to us, discover our rights as patients, and review any other considerations worth keeping in mind! OVERVIEW OF MEDICAL MALPRACTICE LAW AND HOW IT RELATES TO VISITING A HOSPITAL When going to a hospital, concerned patients and their families should be aware of the legal risks posed in medical malpractice cases. These potential issues can have life-altering consequences if misdiagnoses, wrong medication administration, or improper treatment occurs. Now, whether you seek damages for your injuries at Staten Island University Hospital or in a different hospital in your hometown, it is important for visitors to understand that the law has set forth regulations regarding acceptable standards of care expected by our nation's hospitals. Those regulations can include procedures of qualified professionals that protect patients from financial exploitation and physical or emotional distress caused by medical negligence. Understanding how this information applies to you will help you protect yourself legally if your rights are violated while visiting a hospital.

The Department of Health and Social Care (DHSC) has launched a public consultation to gather feedback on government proposals to eliminate modern slavery from the NHS supply chain. This initiative follows a recent government review which revealed that over 21 per cent of NHS suppliers are at high risk of involving modern slavery in the procurement of medical equipment, particularly surgical instruments, gloves, gowns, uniforms, and face masks. The proposed measures would require public bodies procuring goods and services for the NHS to work with suppliers to identify risks and put forward solutions. These new regulations would apply to all public bodies procuring health goods and services, including NHS trusts, integrated care boards, and local authorities. Health Secretary Wes Streeting said: "The NHS is a public service built on compassion and equality, values which are completely antithetical to the heinous evil of modern slavery." "These new measures will ensure vital checks are made and public bodies act to stamp out the crimes of slavery and human trafficking." He also stated that his government will ensure the NHS leads the fight against modern slavery.